Endocytic degradation of ErbB2 mediates the effectiveness of neratinib in the suppression of ErbB2-positive ovarian cancer.
Wang S, Zhang J, Wang T, Ren F, Liu X, Lu Y, Xu L, Zhang Y, Wang D, Xu L, Wu Y, Liu F, Li Q, Zaky MY, Liu S, Dong W, Liu F, Zou K, Zhang Y.
Wang S, et al. Among authors: lu y.
Int J Biochem Cell Biol. 2019 Dec;117:105640. doi: 10.1016/j.biocel.2019.105640. Epub 2019 Nov 2.
Int J Biochem Cell Biol. 2019.
PMID: 31689531